Literature DB >> 16923785

Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax.

Sara Heninger1, Melissa Drysdale, Julie Lovchik, Julie Hutt, Mary F Lipscomb, Theresa M Koehler, C Rick Lyons.   

Abstract

Bacillus anthracis, the etiologic agent of anthrax, produces at least three primary virulence factors: lethal toxin, edema toxin, and a capsule. The capsule is absolutely required for dissemination and lethality in a murine model of inhalation anthrax, yet the roles for the toxins during infection are ill-defined. We show in a murine model that when spores of specific toxin-null mutants are introduced into the lung, dissemination and lethality are comparable to those of the parent strain. Mutants lacking one or more of the structural genes for the toxin proteins, i.e., protective antigen, lethal factor, and edema factor, disseminated from the lung to the spleen at rates similar to that of the virulent parental strain. The 50% lethal dose (LD50) and mean time to death (MTD) of the mutants did not differ significantly from those of the parent. The LD50s or MTDs were also unaffected relative to those of the parent strain when mice were inoculated intravenously with vegetative cells. Nonetheless, histopathological examination of tissues revealed subtle but distinct differences in infections by the parent compared to some toxin mutants, suggesting that the host response is affected by toxin proteins synthesized during infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923785      PMCID: PMC1695493          DOI: 10.1128/IAI.00719-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB.

Authors:  Melissa Drysdale; Agathe Bourgogne; Susan G Hilsenbeck; Theresa M Koehler
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

2.  Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice.

Authors:  Aaron M Firoved; Georgina F Miller; Mahtab Moayeri; Rahul Kakkar; Yuequan Shen; Jason F Wiggins; Elizabeth M McNally; Wei-Jen Tang; Stephen H Leppla
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 3.  Anthrax toxin: a tripartite lethal combination.

Authors:  Paolo Ascenzi; Paolo Visca; Giuseppe Ippolito; Andrea Spallarossa; Martino Bolognesi; Cesare Montecucco
Journal:  FEBS Lett       Date:  2002-11-20       Impact factor: 4.124

4.  Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids.

Authors:  Agathe Bourgogne; Melissa Drysdale; Susan G Hilsenbeck; Scott N Peterson; Theresa M Koehler
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  CapE, a 47-amino-acid peptide, is necessary for Bacillus anthracis polyglutamate capsule synthesis.

Authors:  Thomas Candela; Michèle Mock; Agnès Fouet
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

6.  A dually active anthrax vaccine that confers protection against both bacilli and toxins.

Authors:  Gi-Eun Rhie; Michael H Roehrl; Michael Mourez; R John Collier; John J Mekalanos; Julia Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

7.  Contribution of individual toxin components to virulence of Bacillus anthracis.

Authors:  C Pezard; P Berche; M Mock
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): a calmodulin-dependent adenylate cyclase.

Authors:  D L Robertson; M T Tippetts; S H Leppla
Journal:  Gene       Date:  1988-12-20       Impact factor: 3.688

9.  Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice.

Authors:  Mahtab Moayeri; Diana Haines; Howard A Young; Stephen H Leppla
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 10.  The roles of anthrax toxin in pathogenesis.

Authors:  Mahtab Moayeri; Stephen H Leppla
Journal:  Curr Opin Microbiol       Date:  2004-02       Impact factor: 7.934

View more
  44 in total

1.  Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways.

Authors:  William A Langley; Konrad C Bradley; Zhu-Nan Li; Mary Ellen Smith; Matthias J Schnell; David A Steinhauer
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Anthrax toxin delivers a one-two punch.

Authors:  Kenneth A Bradley; Steven M LeVine
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

3.  Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule.

Authors:  Zhaochun Chen; Rachel Schneerson; Julie Lovchik; C Rick Lyons; Huaying Zhao; Zhongdong Dai; Joanna Kubler-Kielb; Stephen H Leppla; Robert H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

4.  Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Authors:  Mark W Lisanby; Melissa K Swiecki; Brian L P Dizon; Kathryn J Pflughoeft; Theresa M Koehler; John F Kearney
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.

Authors:  Crystal L Loving; Taruna Khurana; Manuel Osorio; Gloria M Lee; Vanessa K Kelly; Scott Stibitz; Tod J Merkel
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

6.  Effect of Bacillus anthracis virulence factors on human dendritic cell activation.

Authors:  Andrew C Hahn; C Rick Lyons; Mary F Lipscomb
Journal:  Hum Immunol       Date:  2008-07-26       Impact factor: 2.850

7.  BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis.

Authors:  Justin Kern; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2009-11-10       Impact factor: 3.501

8.  Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model.

Authors:  Hitendra S Chand; Melissa Drysdale; Julie Lovchik; Theresa M Koehler; Mary F Lipscomb; C Rick Lyons
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

9.  Vaccine protection against Bacillus cereus-mediated respiratory anthrax-like disease in mice.

Authors:  So-Young Oh; Hannah Maier; Jay Schroeder; G Stefan Richter; Derek Elli; James M Musser; Lauriane E Quenee; Dominique M Missiakas; Olaf Schneewind
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

10.  Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.

Authors:  Johnny W Peterson; Jason E Comer; Wallace B Baze; David M Noffsinger; Autumn Wenglikowski; Kristin G Walberg; Jason Hardcastle; Jennifer Pawlik; Kathryn Bush; Joanna Taormina; Scott Moen; John Thomas; Bagram M Chatuev; Laurie Sower; Ashok K Chopra; Lawrence R Stanberry; Ritsuko Sawada; Wolfgang W Scholz; Jagadish Sircar
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.